|
Friday 31st October 2003 |
Text too small? |
The shares investors bought at $2.50 in September 2001 are trading at $1.86 but well above their low of $1.10 last year.
The company has benefited from an increase in patients opting for private medical and surgical attention as public hospitals grapple with unconscionable waiting lists.
It has made no secret of it also looking to benefit from an ageing population, pitting the business squarely in the healthcare sector.
Profit for the year ended March 31 increased 16% to $793,000 after absorbing $258,000 in unusual costs associated with a Securities Commission inquiry into the company's prospectus and listing.
Since then it has appointed former PricewaterhouseCoopers senior manager John Dixon as chief executive and has acquired local counterpart Bowen Hospital.
The improvement coincides with Sir Selwyn Cushing's family trust acquiring a 5% stake.
Wakefield will be looking to consolidate its gains while extracting all it can from the Bowen acquisition. The company is forecasting a "significant increase" in net profit for the 2004 year and should achieve that if patient numbers continue at present levels.
No comments yet
PCT - Precinct FY26 Annual Results
PYS - Mark Samlal retires as PaySauce Director
HGH - Heartland confirms receipt of Toi Foundation approval
SCT - Scott Targets NZ$165m in Protein Revenue by FY30
KPG - Kiwi Property FY27 first quarter dividend payment
August 25th Morning Report
CNU - Board change, closing date for director nominations, & ASM
PFI - PFI Announces FY26 Annual Results
August 24th Morning Report
SKL - Shareholder Register Release